文献速递妇产影像US

子痫前期新定义对发病率及早孕期筛查效果的影响

Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

该回顾性研究纳入66 964例单胎妊娠,按ISSHP旧标准、ACOG新标准及ISSHP新标准分类子痫前期,比较各组分娩孕周、小于胎龄儿发生率及竞争风险模型对早产子痫前期的筛查效果。新标准使子痫前期发病率升高但额外病例病情较轻,早孕期筛查检出率呈非显著下降。

要点

  • 新定义下子痫前期发病率升高:ISSHP旧标准2.8%、ACOG 3.0%、ISSHP新标准3.4%。
  • 新定义额外纳入的病例分娩孕周更晚、小于胎龄儿风险更低,病情相对较轻。
  • 三联试验筛查早产子痫前期在10%假阳性率下检出率:ISSHP旧标准75.9%、ACOG 74.3%、ISSHP新标准74.0%。

核心结论

  • 子痫前期新定义使更多妊娠被分类为子痫前期,但额外病例病情较轻;早孕期筛查效果呈非显著下降。

研究设计与样本

  • 回顾性研究,纳入66 964例单胎妊娠,按ISSHP旧标准、ACOG新标准及ISSHP新标准分类;早孕期筛查采用竞争风险模型,联合母体危险因素、子宫动脉搏动指数、平均动脉压及血清胎盘生长因子(三联试验),于11-13周进行。

诊断标准与关键数值

  • ISSHP旧标准发病率2.8%(1870/66 964),ACOG新标准3.0%(2029/66 964),ISSHP新标准3.4%(2301/66 964)。
  • 三联试验在10%假阳性率下筛查早产子痫前期的检出率:ISSHP旧标准75.9%(95%CI 70.8-80.6%),ACOG 74.3%(95%CI 69.2-79.0%),ISSHP新标准74.0%(95%CI 68.9-78.6%)。
  • 新定义额外病例分娩孕周较ISSHP旧标准组(38.4周)更高:ACOG额外病例差异1.3周(95%CI 0.71-1.71周),ISSHP新标准额外病例差异1.5周(95%CI 1.29-1.71周)。
  • 新定义额外病例小于胎龄儿发生率低于ISSHP旧标准组(33.64%):ACOG额外病例相对风险0.57(95%CI 0.42-0.79),ISSHP新标准额外病例相对风险0.52(95%CI 0.42-0.65)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The traditional definition of pre-eclampsia (PE) is based on the development of hypertension and proteinuria. This has been revised recently to include cases without proteinuria but with evidence of renal, hepatic or hematological dysfunction. The aim of this study was to examine the impact of new definitions of PE on, first, the incidence and severity of the disease and, second, the performance of the competing-risks model for first-trimester assessment of risk for PE.

METHODS: This was a retrospective study of 66 964 singleton pregnancies that were classified as having PE, gestational hypertension (GH) or no PE or GH, according to the traditional criteria of the International Society for the Study of Hypertension in Pregnancy (ISSHP-old), which defines PE as the presence of both hypertension and proteinuria. We reviewed the records of pregnancies with GH, and those cases with high creatinine or liver enzymes or low platelet count were reclassified as having PE, according to the new criteria of ISSHP (ISSHP-new) and the new criteria of the American College of Obstetricians and Gynecologists (ACOG). The groups of PE according to the traditional and new criteria were compared for, first, gestational age at delivery, birth-weight percentile and incidence of a small-for-gestational-age (SGA) neonate with birth weight < 10th percentile and perinatal death, and, second, the predictive performance for preterm PE of the competing-risks model based on the combination of maternal risk factors, uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 11-13 weeks' gestation (triple test).

RESULTS: According to ISSHP-old, 1870 (2.8%) cases had PE, 2182 (3.3%) had GH and 62 912 (94.0%) had no PE or GH. The incidence of PE according to ACOG was 3.0% (2029/66 964) and ISSHP-new was 3.4% (2301/66 964). Median gestational age at delivery in the extra cases of PE according to ACOG (difference, 1.3 weeks; 95% CI, 0.71-1.71 weeks) and in the extra cases of PE according to ISSHP-new (difference, 1.5 weeks; 95% CI, 1.29-1.71 weeks) was higher than in cases with PE according to ISSHP-old (38.4 weeks). The incidence of a SGA neonate in the extra cases of PE according to ACOG (relative risk, 0.57; 95% CI, 0.42-0.79) and in the extra cases of PE according to ISSHP-new (relative risk, 0.52; 95% CI, 0.42-0.65) was lower than in the cases of PE according to ISSHP-old (33.64%). In first-trimester screening for preterm PE by the triple test, the detection rate, at a 10% false-positive rate, was 75.9% (95% CI, 70.8-80.6%) for ISSHP-old, 74.3% (95% CI, 69.2-79.0%) for ACOG and 74.0% (95% CI, 68.9-78.6%) for ISSHP-new.

CONCLUSIONS: The new definitions of PE resulted in, first, an increase in pregnancies classified as having PE but the additional cases had milder disease, and, second, a non-significant decrease in the performance of first-trimester screening for PE. © 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Khan N, Andrade W, De Castro H, et al. Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening. Ultrasound Obstet Gynecol. 2020. PMID: 31503372. doi:10.1002/uog.21867

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。